(1) Only acceptable quality reclaimed water
shall be discharged to reuse systems regulated under Part V of this
chapter.
(2) Reclaimed water
limitations shall be met before injection to ground water or discharge to
surface waters. For projects requiring high-level disinfection, the TSS
limitation shall be achieved before disinfection, regardless of the actual
reclaimed water compliance monitoring location.
(3) The treatment facility shall include
continuous on-line monitoring for turbidity before application of the
disinfectant. Continuous monitoring for total residual chlorine or for residual
concentrations of other disinfectants, if used, shall be provided at the
compliance monitoring point. Instruments for continuous on-line monitoring
shall be equipped with an automated data logging or recording device.
Continuous online monitoring instruments shall be calibrated according to the
requirements of Chapters 62-160 and 62-600, F.A.C. Continuous online monitoring
instruments shall be maintained according to the manufacturer's operation and
maintenance instructions.
(4)
Treatment facilities designed to meet the full treatment and disinfection
requirements shall have the reclaimed water sampled and analyzed for TOC and
TOX daily, seven days per week.
(5)
Treatment facilities that are required to meet the drinking water standards
shall sample the reclaimed water for parameters regulated as drinking water
standards as follows:
(a) If the treatment
facility is required to meet the bacteriological requirements of the drinking
water standards, total coliforms and total suspended solids shall be analyzed
daily.
(b) Parameters listed as
primary drinking water standards that are imposed as reclaimed water limits
shall be analyzed monthly. After the first year, the Department shall reduce
the monitoring frequency if the applicant provides an affirmative demonstration
that reclaimed water limits and ground water standards will be met and that
public health will be protected. In no case shall the frequency of this
monitoring be reduced below quarterly.
(c) Parameters listed as secondary drinking
water standards that are imposed as reclaimed water limits shall be analyzed
quarterly. After the first year, the Department shall reduce the monitoring
frequency if the applicant provides an affirmative demonstration that reclaimed
water limits and ground water standards will be met and that public health will
be protected. In no case shall the frequency of this monitoring be reduced
below annually. The pH of the reclaimed water shall be analyzed
daily.
(d) Except for total
coliforms and pH, twenty-four hour composite samples shall be used to analyze
the reclaimed water for parameters listed as primary or secondary drinking
water standards.
(6)
Other reclaimed water monitoring shall meet the requirements of Chapter 62-600,
F.A.C.
(7) In accordance with Rule
62-610.320, F.A.C., the
permittee shall develop, and the Department shall approve, an operating
protocol designed to ensure that the reclaimed water limitations will be met
before the reclaimed water is released to the reuse system. For treatment
facilities required to provide full treatment and disinfection, the operating
protocol shall include monitoring and control of key treatment processes for
removal of organic compounds required by subsection
62-610.563(3),
F.A.C., and shall incorporate the fail safe "lock-out" provisions of subsection
62-610.567(2),
F.A.C. In the engineering report, the applicant shall describe and justify the
operational controls on the key treatment processes for removal of organic
compounds. Reclaimed water produced at the treatment facility that fails to
meet the criteria established in the operating protocol shall not be released
to the system storage or reuse system. Such substandard reclaimed water (reject
water) shall be either stored for subsequent additional treatment or shall be
discharged to another permitted reuse system requiring lower levels of
preapplication treatment or to a permitted effluent disposal system. The
operating protocol shall be reviewed and updated by the permittee as required
by Rule
62-610.320, F.A.C. The permittee
shall submit the current operating protocol to the Department for review with
any application to renew or modify the permit.
(8) Ground water monitoring requirements
shall be as specified in Rule
62-610.412, F.A.C. A ground
water monitoring plan meeting the requirements of Chapters 62-520, 62-600, and
62-610, F.A.C., is required. Submittal and approval of ground water monitoring
plans shall be in accordance with Rule
62-520.600, F.A.C. Department
approval of the ground water monitoring plan is a prerequisite for issuance of
the initial permit.
(9) The surface
water or ground water receiving the reclaimed water shall be sampled quarterly
for the parameters for which primary or secondary drinking water standards have
been established. After the first year of operation, the Department shall
reduce the sampling frequency if the applicant provides an affirmative
demonstration that water quality standards will be met in the receiving surface
water or ground water and that public health will be protected. For ground
water recharge projects, reductions in monitoring shall be considered only
after the injected reclaimed water reaches a monitoring well. The complete list
of all regulated parameters shall be sampled and analyzed for at least
annually.
(10) Except as noted in
subsection
62-610.568(11),
F.A.C., the permittee shall sample the reclaimed water for Cryptosporidium and
Giardia. The following requirements shall be met:
(a) Sampling shall be conducted quarterly.
Intervals between sampling shall not exceed three months. The sample results
shall be submitted to the Department on or before February 28, May 28, August
28, and November 28 of each year using Form
62-610.300(3)(a)
4., Pathogen Monitoring, (adopted and incorporated by reference in subparagraph
62-610.300(3)(a)
4., F.A.C., effective August 8, 2021,
http://www.flrules.org/Gateway/reference.asp?No=Ref-13373).
(b) Samples shall be taken at a point
immediately following the final treatment or disinfection process within the
treatment facility.
(c) Sampling
for Cryptosporidium and Giardia shall be required only for the following types
of projects:
1. Discharge to Class I surface
waters, as described in Rule
62-610.554, F.A.C.
2. Discharge to waters contiguous to or
tributary to Class I surface waters, as described in subsection
62-610.555(1),
F.A.C.
3. Injection projects used
for ground water recharge or salinity barrier control, as described in Rule
62-610.560 or
62-610.562, F.A.C.
4. Discharges to surface waters that are
directly connected to ground water, which serve as ground water recharge, as
described in subsection
62-610.555(4),
F.A.C.
(d) Samples shall
be taken during peak flow periods between the months of August and
October.
(e) If the wastewater
treatment facility uses chlorination for disinfection, samples collected for
analysis of Giardia and Cryptosporidium shall be dechlorinated.
(f) A grab sample for TSS shall be taken such
that it is representative of the water leaving the filters at the treatment
facility during the period when pathogen samples are taken. In addition, the
permittee shall record the lowest total residual chlorine observed during the
period when pathogen samples are collected.
(g) EPA Method 1623.1, (adopted and
incorporated by reference in subsection
62-610.100(7),
F.A.C., effective August 8, 2021,
http://www.flrules.org/Gateway/reference.asp?No=Ref-13382),
or other approved methods in accordance with Rule
62-160.330, F.A.C., for
reclaimed water or nonpotable waters, adjusted appropriately to accommodate the
detection limit requirements, shall be used. Methods previously allowed for
EPA's ICR shall not be used. The full requirements of the approved method,
including quality assurance and quality control, are to be met. Quality
assurance and sampling requirements in Chapter 62-160, F.A.C., shall apply. Two
concentrations of Giardia and Cryptosporidium shall be recorded on Part III of
Form
62-610.300(3)(a)
4., Pathogen Monitoring, (adopted and incorporated by reference in subparagraph
62-610.300(3)(a)
4., F.A.C., effective August 8, 2021,
http://www.flrules.org/Gateway/reference.asp?No=Ref-13373).
2. Potentially viable cysts and oocysts shall
be enumerated using the DAPI staining technique contained in EPA Method 1623.1,
(adopted and incorporated by reference in subsection
62-610.100(7),
F.A.C., effective August 8, 2021,
http://www.flrules.org/Gateway/reference.asp?No=Ref-13382),
or similar enumeration techniques included in other approved methods in
accordance with Rule
62-160.330, F.A.C. Cysts and
oocysts that are stained DAPI positive or show internal structure by D.I.C.
shall be considered as being potentially viable. If the laboratory reports
separate values for DAPI positive and for cysts or oocysts having internal
structure, the larger of the two concentrations will be reported as being
potentially viable.
(h)
If the number of potentially viable cysts of Giardia reported exceeds 5 per 100
liters or oocysts of Cryptosporidium reported exceeds 22 per 100 liters, a
subsequent sample shall be taken and analyzed using EPA Method 1623.1, (adopted
and incorporated by reference in subsection
62-610.100(7),
F.A.C., effective August 8, 2021,
http://www.flrules.org/Gateway/reference.asp?No=Ref-13382),
or other approved methods in accordance with Rule
62-160.330, F.A.C. This
subsequent sample shall be collected within 90 days of the date the initial
sample was taken, analyzed for both Giardia and Cryptosporidium, and the
results of the subsequent analysis shall be submitted to the Department within
60 days of sample collection using Form
62-610.300(3)(a)
4., Pathogen Monitoring, (adopted and incorporated by reference in subparagraph
62-610.300(3)(a)
4., F.A.C., effective August 8, 2021,
http://www.flrules.org/Gateway/reference.asp?No=Ref-13373).
(11) For projects involving
discharge to waters upstream of Class I surface waters, as described in
subsection
62-610.555(2),
F.A.C., the permittee shall sample the reclaimed water for Cryptosporidium and
Giardia. The following requirements shall be met:
(a) Sampling shall be conducted at one time
during each two-year period. Intervals between sampling shall not exceed two
years. The sample results shall be submitted to the Department on or before
November 28 of each even numbered year using Form
62-610.300(3)(a)
4., Pathogen Monitoring, (adopted and incorporated by reference in subparagraph
62-610.300(3)(a)
4., F.A.C., effective August 8, 2021,
http://www.flrules.org/Gateway/reference.asp?No=Ref-13373).
(b) Samples shall be taken at a point
immediately following the disinfection process.
(c) Samples shall be taken during peak flow
periods between the months of August and October.
(d) If the wastewater treatment facility uses
chlorination for disinfection, samples collected for analysis of Giardia and
Cryptosporidium shall be dechlorinated.
(e) A grab sample for TSS shall be taken such
that it is representative of the water leaving the filters at the treatment
facility during the period when pathogen samples are taken. In addition, the
permittee shall record the lowest total residual chlorine observed during the
period when pathogen samples are collected.
(f) EPA Method 1623.1, (adopted and
incorporated by reference in subsection
62-610.100(7),
F.A.C., effective August 8, 2021,
http://www.flrules.org/Gateway/reference.asp?No=Ref-13382),
or other approved methods in accordance with Rule
62-160.330, F.A.C., for
reclaimed water or nonpotable waters, adjusted appropriately to accommodate the
detection limit requirements, shall be used. Methods previously allowed for
EPA's ICR shall not be used. The full requirements of the approved method,
including quality assurance and quality control, are to be met. Quality
assurance and sampling requirements in Chapter 62-160, F.A.C., shall apply.
Two concentrations of Giardia and Cryptosporidium shall be
recorded on Part III of Form
62-610.300(3)(a)
4., Pathogen Monitoring, (adopted and incorporated by reference in subparagraph
62-610.300(3)(a)
4., F.A.C., effective August 8, 2021,
http://www.flrules.org/Gateway/reference.asp?No=Ref-13373).
2. Potentially viable cysts and oocysts shall
be enumerated using the DAPI staining technique contained in EPA Method 1623.1,
(adopted and incorporated by reference in subsection
62-610.100(7),
F.A.C., effective July 2021), or similar enumeration techniques included in
other approved methods in accordance with Rule
62-160.330, F.A.C. Cysts and
oocysts that are stained DAPI positive or show internal structure by D.I.C.
shall be considered as being potentially viable. If the laboratory reports
separate values for DAPI positive and for cysts or oocysts having internal
structure, the larger of the two concentrations will be reported as being
potentially viable.
(g)
If the number of potentially viable cysts of Giardia reported exceeds 5 per 100
liters or oocysts of Cryptosporidium reported exceeds 22 per 100 liters, a
subsequent sample shall be taken and analyzed using EPA Method 1623.1, (adopted
and incorporated by reference in subsection
62-610.100(7),
F.A.C., effective July 2021), or other approved methods in accordance with Rule
62-160.330, F.A.C. This
subsequent sample shall be collected within 90 days of the date the initial
sample was taken, analyzed for both Giardia and Cryptosporidium, and the
results of the subsequent analysis shall be submitted to the Department within
60 days of the sample collections using Form
62-610.300(3)(a)
4., Pathogen Monitoring, (adopted and incorporated by reference in subparagraph
62-610.300(3)(a)
4., F.A.C., effective August 8, 2021,
http://www.flrules.org/Gateway/reference.asp?No=Ref-13373).
Notes
Fla. Admin. Code Ann. R.
62-610.568
Rulemaking Authority
403.051,
403.061,
403.064,
403.087 FS. Law Implemented
403.021,
403.051,
403.061,
403.062,
403.064,
403.085,
403.086,
403.087,
403.088
FS.
New 4-4-89, Amended 4-2-90, Formerly 17-610.568,
Amended 1-9-96, 8-8-99, 11-19-07, Amended by
Florida
Register Volume 47, Number 144, July 27, 2021 effective
8/8/2021, Amended by
Florida
Register Volume 51, Number 028, February 11, 2025 effective
2/26/2025.
New 4-4-89, Amended 4-2-90, Formerly 17-610.568, Amended
1-9-96, 8-8-99, 11-19-07, 8-8-21.